A new Truveta study offers a hopeful sign: Syphilis incidence is down for the first time in decades
Published in the American Journal of Preventative Medicine, the new study shows that for the first time since its peak in 2022, syphilis incidence has declined,…
New Truveta data and capabilities help researchers accelerate scientifically rigorous research
BELLEVUE, Wash. – March 26, 2025 – Today, Truveta announced that Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of…
Truveta Data expands beyond EHR data with linked closed claims for more than 200 million patients
Closed claims complete the longitudinal patient journey in Truveta Data, enabling regulatory grade safety and effectiveness studies, replacing clinical trials and registries BELLEVUE, Wash. – February…
New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications
New research published in JAMA Network Open led by Truveta Research and Ezekiel Emanuel, MD, PhD, Perelman School of Medicine at University of Pennsylvania BELLEVUE, Wash.…
US health systems announce the Truveta Genome Project, creating the world’s largest and most diverse database to discover the science of humanity
Truveta achieves HITRUST r2 Certification, demonstrating the highest level of information protection assurance
HITRUST r2 Certification demonstrates Truveta’s relentless commitment to the highest standards of security and privacy to protect regulatory-grade data. BELLEVUE, Wash. – November 20, 2024 –…
Truveta Data, the most complete, timely, and clean electronic health record data, now includes more than 120 million de-identified patients
Researchers with more than 100 organizations use regulatory-grade Truveta Data to enable their scientifically rigorous research BELLEVUE, Wash. – November 14, 2024 –Truveta announced today that…
Truveta Studio now includes Truveta Tru, a research assistant powered by generative AI
Trained on the Truveta Language Model and Truveta Data, the most complete and representative EHR data, Tru enables researchers to accelerate their research in Truveta Studio…
The CHOICE Institute partners with Truveta to advance health economics and outcomes research
Truveta will enable The CHOICE Institute with complete, timely, and clean real-world data to improve patient care and advance medicine The Comparative Health Outcomes, Policy, and…
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss published in JAMA Internal Medicine
In the largest comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data – now published in JAMA Internal Medicine –…
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
With industry-leading certifications and rigorous third-party audits, Truveta announces new capabilities to enable successful regulatory submissions and audits. BELLEVUE, Wash. – June 18, 2024 – Today,…
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
BELLEVUE, Wash. – May 13, 2024 – Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data,…
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research
From detailed family history and complex concepts from a wide range of therapeutic areas to millions of de-identified medical images, Truveta empowers researchers with the most…
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
BELLEVUE, Wash. – April 25, 2024 – Truveta, the company with a mission of Saving Lives with Data, announced today the largest and most complete mother-child…
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
BELLEVUE, Wash. – January 22, 2024 – Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was…
Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics
In a study of more than 2.4 million children under the age of 5, new research shows a significant increase in the rate of first-time speech…
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
BELLEVUE, Wash. – December 4, 2023 – Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science…
Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research found that patients with overweight or…
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
BELLEVUE, Wash. – October 23, 2023 – Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical…
Truveta advances security and privacy with Type 2 SOC 2 examination
Truveta has completed its Type 2 SOC 2 examination and continue to maintain ISO 27001 certifications, demonstrating the company’s relentless commitment to security, privacy, and trust.…
Partnership news: Truveta and Mathematica to advance public health and health equity with real-world data
Powerful partnership will allow researchers access to the most complete, timely, and clean health data to improve outcomes BELLEVUE, Wash. and PRINCETON, New Jersey – September…
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
Truveta Data will enable Medical Components, Inc. to study manufacturer-specific medical device data to address medical evidence gaps and improve clinical care recommendations. BELLEVUE, Wash. –…
Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
With new medication dispense data – including prescription fill data from specialty pharmacies – Truveta Data offers even more complete, timely, and clean data to study…